Clinical trials
Osteoporosis clinical trials
Below are recruiting osteoporosis clinical trials, each written for real people, not researchers. We’re tracking 124 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07365514RecruitingPhase 1
Blackcurrants study for bone health in postmenopausal women
This trial tests if taking a blackcurrant supplement can help maintain bone density and reduce osteoporosis risk in postmenopausal women. You will take daily capsules and provide blood, stool, and bone scan samples over the study period.
Storrs, ConnecticutAges 45–70 - NCT06864130RecruitingPhase 4
Stopping Alendronate in osteoporosis after no fractures
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
AalborgAges Any age - NCT07303166Recruiting
Osteoporosis care decisions for frail elderly patients
This study learns from doctors in Alsace who treat osteoporosis in frail older patients. It aims to understand what helps or hinders their use of a practical guide. If you are a doctor who has used this guide, your insights could improve future care.
StrasbourgAges 18 years+ - NCT07296471Recruiting
Vitamin D and Bone Health Study
This study is looking at how vitamin D levels relate to bone health and overall health markers in people with and without osteoporosis. It aims to find better ways to understand and treat bone loss.
Yichang, HubeiAges 18 years+ - NCT07281586RecruitingPhase 4
Switching from Prolia to a different osteoporosis drug
This trial tests if it's safe to switch from a long-term osteoporosis medication called Prolia to another treatment. It may help women and men who have been on Prolia for at least 3 years.
Douliu, TaiwanAges 50–85 - NCT07283887RecruitingPhase 4
Romosozumab and Denosumab for Postmenopausal Osteoporosis
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
Douliu, TaiwanAges 50–80 - NCT07228611Recruiting
Osteoporosis risk after stroke
This study looks at bone health in people who have had a stroke. It aims to find out who is at risk for weak bones (osteoporosis) after a stroke, so doctors can help prevent fractures.
Ankara, YenimahalleAges 55–85 - NCT06947213Recruiting
Orthorexia nervosa in women with postmenopausal osteoporosis
This study looks at whether women with osteoporosis after menopause have a higher risk of orthorexia nervosa, an unhealthy obsession with healthy eating. It aims to compare women with and without osteoporosis to understand the connection.
IstanbulAges 55–75 - NCT07067827Recruiting
Osteoporosis survey for clinic patients
This trial tests a self-questionnaire for people with osteoporosis who are already being followed at certain clinics. It aims to see if the questionnaire helps manage the condition.
Québec, QuebecAges 18 years+ - NCT07030205Recruiting
Brain imaging study for women with osteoporosis
This study uses brain scans (MRI) to look at how the brain might be linked to bone health in women with osteoporosis. It compares women with osteoporosis to healthy women of the same age.
Clermont-FerrandAges 50 years+ - NCT06767150RecruitingPhase 4
Bone treatment after stopping denosumab for osteoporosis
This trial tests whether giving zoledronic acid (a bone-strengthening infusion) right after stopping denosumab can help prevent bone loss in women with post-menopausal osteoporosis. It may be a good option if you have finished at least 2 years of denosumab and your doctor says it's safe to stop.
AmiensAges 18 years+ - NCT06741956Enrolling by invitation
Wearable device for osteoporosis prevention in women
This trial tests a wearable device designed to help prevent osteoporosis and reduce fracture risk in women who have recently gone through menopause. The goal is to see if the device can help you stay active and lower your chances of breaking a bone.
Seville, SpainAges 40 years+ - NCT06558188RecruitingPhase 4
Combined bone-building therapy for osteoporosis
This study tests a combination of two bone-building drugs (romosozumab and teriparatide) in postmenopausal women with osteoporosis who are at high risk for fractures. The goal is to see if the combination strengthens bones faster and better than either drug alone.
Boston, MassachusettsAges 45 years+ - NCT06395883Recruiting
Steroids and Your Bones in Joint Disease
This study looks at how steroids affect bone health in people with inflammatory joint diseases like rheumatoid arthritis. Researchers will track markers in your blood to see if short-term steroid use impacts your bones.
DrammenAges 25–90 - NCT05787808Recruiting
Preventive treatment for people with early bone loss
This trial studies a preventive treatment for people over 55 who have early bone thinning (called osteopenia). If you qualify, it may help reduce the risk of getting osteoporosis and related fractures.
Skjetten, AkershusAges 55–85 - NCT06264609Enrolling by invitationPhase 4
Precision follow-up study for osteoporosis treatment
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
Lexington, KentuckyAges 45 years+ - NCT06118905RecruitingPhase 4
Osteoporosis medication to preserve muscle in seniors
This study tests whether an osteoporosis medication can help preserve muscle strength in older adults who live in senior facilities. It's for people age 65+ with fragile bones or low bone density who are at risk for falls and fractures.
Pittsburgh, PennsylvaniaAges 65 years+ - NCT05688969Recruiting
Study of how an osteoporosis shot works in postmenopausal women
This study looks at what changes in the body after starting romosozumab (an osteoporosis treatment) in postmenopausal women at higher risk for fractures. Researchers want to understand the treatment’s “mechanism,” which may help improve future osteoporosis care.
Boston, MassachusettsAges 45 years+ - NCT05571514Recruiting
Pearl supplement study to help prevent menopause-related bone loss
This study tests whether a “mother-of-pearl” nutritional supplement can help prevent osteoporosis after menopause. You may qualify if you’re a post-menopausal woman with lower-than-normal bone density but without past fragility fractures.
Clermont-FerrandAges 50–65 - NCT02635022Recruiting
Care plan plus bone-medicine monitoring after a fracture
This study tests a structured care service to help people manage osteoporosis after a new bone fragility fracture. It aims to improve how you take bone-protecting medicines and to make sure treatment is followed and monitored over time.
HsinchuAges 50 years+ - NCT05039216Recruiting
Biobank for inflammatory arthritis and osteoporosis
This study collects and stores health information and samples for people with long-term inflammatory arthritis (like rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis) or with osteoporosis. It helps researchers understand these conditions and may lead to better future treatments.
ToulouseAges 18–99 - NCT04704947RecruitingPhase 3
Beta blockers and fracture risk in osteoporosis
This study tests whether using beta blocker blood pressure medicines affects the risk of fractures in people with osteoporosis. It may help doctors understand which medication choices lower fracture risk.
TantaAges 50 years+ - NCT05906147Recruiting
Bone health improvement program for adults over 40
This study tests a structured bone health improvement program for adults over age 40 who are attending a health checkup at the hospital. It aims to improve or maintain bone strength, using bone density measurements as part of the study.
Changsha, HunanAges 40–100 - NCT06065852Recruiting
National registry for rare kidney diseases
This study creates a registry to collect health information from people with rare kidney diseases. It aims to improve understanding and future treatments by tracking patient experiences.
Bristol, South WestAges Any age
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for osteoporosis?
- Yes. Clin2 currently lists 124 recruiting osteoporosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a osteoporosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a osteoporosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.